BSE filing, NSE: SANOFICONR. Summary written from the filing by ALFA Finder's alert engine.
Sanofi Consumer Healthcare India Ltd: key numbers
- Share price
- ₹3,333.00
- Market cap
- ₹7,676 Cr
- Revenue (annual)
- ₹878.4 Cr
- Net profit (annual)
- ₹240.1 Cr
- P/E (TTM)
- 28.9×Sector 46.5×
- Promoter holding
- 71.27%+0.00% QoQ
- FII holding
- 2.48%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanofi Consumer Healthcare India Ltd
All →Sanofi Consumer Healthcare India Q2 FY27 Results: Net Profit ₹76.6 Cr, Up 21.8% YoY
Sanofi Consumer Healthcare India Ltd reported revenue from operations of ₹263.1 Cr (+12.5% YoY) and net profit of ₹76.6 Cr (+21.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹76.6 Cr · +21.8% YoY
Sanofi Consumer Healthcare India Board Meeting Date
Sanofi Consumer Healthcare India Limited will hold a board meeting on 28 October 2026 to consider its standalone unaudited financial results for the September 2026 quarter.
Sanofi Consumer Healthcare India Q1 FY27 Results: Net Profit ₹68.8 Cr, Up 13.3% YoY
Sanofi Consumer Healthcare India Ltd reported revenue from operations of ₹235.7 Cr (+6.7% YoY) and net profit of ₹68.8 Cr (+13.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹68.8 Cr · +13.3% YoY
Sanofi Consumer Healthcare India Board Meeting Date
Sanofi Consumer Healthcare India Limited will hold a board meeting on 28th July 2026 to consider and approve its unaudited financial results.
Sanofi Consumer Healthcare India Other Announcement
The company filed its quarterly shareholding pattern for the period ending June 30, 2026, detailing the distribution of equity among promoter and public shareholders.
Sanofi Consumer Healthcare India Management Change
Sanofi Consumer Healthcare India appointed PwC as Statutory Auditor. The term spans five consecutive years until the 8th AGM in 2031.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.